首页 | 本学科首页   官方微博 | 高级检索  
     


Systemic Therapy for Hepatocellular Carcinoma and Cholangiocarcinoma
Affiliation:1. Taussig Cancer Institute, Department of Hematology and Oncology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA;2. Digestive Disease Institute, Department of Colorectal Surgery, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA;3. Digestive Disease Institute, HPB and Liver Transplant Program, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA;1. Division of Surgical Oncology, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA;2. Division of Surgical Oncology, Department of Surgery, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA;1. Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA;2. Division of General Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA;3. Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA;1. Department of Surgery, Johns Hopkins Hospital, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 688, Baltimore, MD 21287, USA;2. Department of Surgery, University of California-Irvine, 333 City Boulevard West, Suite 1205, Orange, CA 92868, USA;3. Division of Surgical Oncology, Department of Surgery, Johns Hopkins Hospital, 600 North Wolfe Street, Blalock 688, Baltimore, MD 21287, USA
Abstract:
Keywords:Hepatocellular carcinoma  Cholangiocarcinoma  Chemotherapy  Molecular targets
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号